West Pharmaceutical Services, Inc.
Health
Performance
4.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

West Pharmaceutical Services, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

07.07.2026
Losing steam. Solid pieces remain, but cracks are showing.
12.06.2026
Risk creeping up. Stability not bulletproof anymore.
17.04.2026
Slight bounce. Could be noise – or a comeback brewing.
20.08.2025
Back in top shape. Balance sheet solid, outlook sharp.
WST
West Pharmaceutical Services, Inc.
359.24
+1.96%
4.6
Sell
Buy
West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does West Pharmaceutical Services, Inc. do? Business model and key facts

Get the full picture of West Pharmaceutical Services, Inc.: what it builds, where it operates, and how it makes money.

West Pharmaceutical Services, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 10800

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

shop
Company facts
Eric Green
CEO
10800
Employees worldwide
shop
Performance
71%
Last 12 months
-2.37%
Last 5 years
shop
Growth
$3.07B
Revenue year
$493.70M
Net income
shop
Valuation
$25.33B
Market Cap
40.28
Price/Earnings Ratio

Stocks related to West Pharmaceutical Services, Inc.

Selected based on industry alignment and relative market positioning.

BDX
Low-poly 3D Becton Dickinson (BDX) stock icon with a stylized syringe, symbolizing healthcare and medical devices.
153.84
-0.41%
3.0
Sell
Buy
Becton, Dickinson and Company
HOLX
Hologic, Inc.
76.01
+0.00%
1.8
Sell
Buy
Hologic, Inc.
COO
The Cooper Companies, Inc.
71.01
-0.81%
3.9
Sell
Buy
The Cooper Companies, Inc.
BAX
Baxter International Inc.
22.21
+0.63%
5.8
Sell
Buy
Baxter International Inc.
ATR
AptarGroup, Inc.
128.91
-0.77%
4.9
Sell
Buy
AptarGroup, Inc.

Events and news impacting West Pharmaceutical Services, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

West Pharmaceutical Services, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.